ClinicalTrials.govpublic full text
Valganciclovir to Reduce T Cell Activation in HIV Infection
hiv infections, cytomegalovirus infections, hiv, cmv, t cell activation, valganciclovir, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829455
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.